Literature DB >> 34732887

Disruption of mitochondrial complex I induces progressive parkinsonism.

Patricia González-Rodríguez1, Enrico Zampese1, Kristen A Stout1, Jaime N Guzman1, Ema Ilijic1, Ben Yang1, Tatiana Tkatch1, Mihaela A Stavarache2, David L Wokosin1, Lin Gao3, Michael G Kaplitt2, José López-Barneo3, Paul T Schumacker4, D James Surmeier5.   

Abstract

Loss of functional mitochondrial complex I (MCI) in the dopaminergic neurons of the substantia nigra is a hallmark of Parkinson's disease1. Yet, whether this change contributes to Parkinson's disease pathogenesis is unclear2. Here we used intersectional genetics to disrupt the function of MCI in mouse dopaminergic neurons. Disruption of MCI induced a Warburg-like shift in metabolism that enabled neuronal survival, but triggered a progressive loss of the dopaminergic phenotype that was first evident in nigrostriatal axons. This axonal deficit was accompanied by motor learning and fine motor deficits, but not by clear levodopa-responsive parkinsonism-which emerged only after the later loss of dopamine release in the substantia nigra. Thus, MCI dysfunction alone is sufficient to cause progressive, human-like parkinsonism in which the loss of nigral dopamine release makes a critical contribution to motor dysfunction, contrary to the current Parkinson's disease paradigm3,4.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34732887      PMCID: PMC9189968          DOI: 10.1038/s41586-021-04059-0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  52 in total

1.  Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress.

Authors:  Jaime N Guzman; Ema Ilijic; Ben Yang; Javier Sanchez-Padilla; David Wokosin; Dan Galtieri; Jyothisri Kondapalli; Paul T Schumacker; D James Surmeier
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

2.  Biotransformation of L-DOPA to dopamine in the substantia nigra of freely moving rats: effect of dopamine receptor agonists and antagonists.

Authors:  S Sarre; D Vandeneede; G Ebinger; Y Michotte
Journal:  J Neurochem       Date:  1998-04       Impact factor: 5.372

Review 3.  The functional anatomy of basal ganglia disorders.

Authors:  R L Albin; A B Young; J B Penney
Journal:  Trends Neurosci       Date:  1989-10       Impact factor: 13.837

4.  The efficiency of systematic sampling in stereology and its prediction.

Authors:  H J Gundersen; E B Jensen
Journal:  J Microsc       Date:  1987-09       Impact factor: 1.758

5.  Cell-type-specific isolation of ribosome-associated mRNA from complex tissues.

Authors:  Elisenda Sanz; Linghai Yang; Thomas Su; David R Morris; G Stanley McKnight; Paul S Amieux
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

6.  Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain.

Authors:  F C Zhou; S Bledsoe; J Murphy
Journal:  Brain Res       Date:  1991-08-09       Impact factor: 3.252

7.  Total number of neurons in the neostriatal, pallidal, subthalamic, and substantia nigral nuclei of the rat basal ganglia: a stereological study using the cavalieri and optical disector methods.

Authors:  D E Oorschot
Journal:  J Comp Neurol       Date:  1996-03-18       Impact factor: 3.215

8.  Collateralization and GAD immunoreactivity of descending pallidal efferents.

Authors:  L Schmued; P Phermsangngam; H Lee; S Thio; E Chen; P Truong; E Colton; J Fallon
Journal:  Brain Res       Date:  1989-05-15       Impact factor: 3.252

9.  The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice.

Authors:  Valentine Bouet; Michel Boulouard; Jérôme Toutain; Didier Divoux; Myriam Bernaudin; Pascale Schumann-Bard; Thomas Freret
Journal:  Nat Protoc       Date:  2009-10-01       Impact factor: 13.491

10.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

View more
  49 in total

1.  Modulation of nigral dopamine signaling mitigates parkinsonian signs of aging: evidence from intervention with calorie restriction or inhibition of dopamine uptake.

Authors:  Michael F Salvatore; Ella A Kasanga; D Parker Kelley; Katy E Venable; Tamara R McInnis; Mark A Cantu; Jennifer Terrebonne; Kathryn Lanza; Samantha M Meadows; Ashley Centner; Christopher Bishop; Donald K Ingram
Journal:  Geroscience       Date:  2022-05-30       Impact factor: 7.713

2.  PARK7/DJ-1 promotes pyruvate dehydrogenase activity and maintains Treg homeostasis during ageing.

Authors:  Egle Danileviciute; Ni Zeng; Christophe M Capelle; Nicole Paczia; Mark A Gillespie; Henry Kurniawan; Mohaned Benzarti; Myriam P Merz; Djalil Coowar; Sabrina Fritah; Daniela Maria Vogt Weisenhorn; Gemma Gomez Giro; Melanie Grusdat; Alexandre Baron; Coralie Guerin; Davide G Franchina; Cathy Léonard; Olivia Domingues; Sylvie Delhalle; Wolfgang Wurst; Jonathan D Turner; Jens Christian Schwamborn; Johannes Meiser; Rejko Krüger; Jeff Ranish; Dirk Brenner; Carole L Linster; Rudi Balling; Markus Ollert; Feng Q Hefeng
Journal:  Nat Metab       Date:  2022-05-26

Review 3.  Inflammasome Activation in Parkinson's Disease.

Authors:  Shannon Jewell; Ashane M Herath; Richard Gordon
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

4.  Expanding Views of Mitochondria in Parkinson's Disease: Focusing on PINK1 and GBA1 Mutations.

Authors:  Yu Yuan; Xizhen Ma; Ning Song; Junxia Xie
Journal:  Neurosci Bull       Date:  2022-05-11       Impact factor: 5.271

5.  Altered prefrontal neurochemistry in the DJ-1 knockout mouse model of Parkinson's disease: complementary semi-quantitative analyses with in vivo magnetic resonance spectroscopy and MALDI-MSI.

Authors:  Wei Chen; Huihui Liu; Sijie Liu; Yan Kang; Zongxiu Nie; Hao Lei
Journal:  Anal Bioanal Chem       Date:  2022-10-08       Impact factor: 4.478

6.  Mitochondrial Dysregulation and the Influence in Neurodegenerative Diseases.

Authors:  Giuliana S Zuccoli; Victor Corasolla Carregari
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 7.  Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson's Disease.

Authors:  Irene Sanchez-Mirasierra; Saurav Ghimire; Sergio Hernandez-Diaz; Sandra-Fausia Soukup
Journal:  Front Cell Dev Biol       Date:  2022-07-06

8.  Early Forms of α-Synuclein Pathology Are Associated with Neuronal Complex I Deficiency in the Substantia Nigra of Individuals with Parkinson's Disease.

Authors:  Irene Hana Flønes; Harald Nyland; Dagny-Ann Sandnes; Guido Werner Alves; Ole-Bjørn Tysnes; Charalampos Tzoulis
Journal:  Biomolecules       Date:  2022-05-25

Review 9.  Hallmarks and Molecular Tools for the Study of Mitophagy in Parkinson's Disease.

Authors:  Thomas Goiran; Mohamed A Eldeeb; Cornelia E Zorca; Edward A Fon
Journal:  Cells       Date:  2022-07-02       Impact factor: 7.666

10.  Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity.

Authors:  David Pamies; Daphne Wiersma; Moriah E Katt; Liang Zhao; Johannes Burtscher; Georgina Harris; Lena Smirnova; Peter C Searson; Thomas Hartung; Helena T Hogberg
Journal:  Neurobiol Dis       Date:  2022-04-07       Impact factor: 7.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.